Some of these chemokines and receptors, such as CXCL13, CCL4, CCL5, CCR2, CXCR3, and CXCR4, have been experimentally confirmed to be associated with the pathogenesis or prognosis of gastric cancer or other malignancies [39, 40–43]. This evidence concerns the gene CCR2 and gastric cancer.